STEAP and WDR18 are involved in ion transport and RNA metabolism, processes that have been previously reported as dysregulated in MS [49, 50], while mutations in POC5 have been associated with increased BMI [50], a known risk factor for MS [54]. The gene discussed is STEAP1; the disease is myeloid sarcoma.